Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01416584 · ClinicalTrials.gov registry record · NA
A Bridge to Treatment: The Therapeutic Workplace and Methadone Treatment
A NA study, sponsored by Johns Hopkins University.
- Completed
- Registry status
- NA
- Development phase
- 98
- Enrollment target
NCT01416584: Completed NA study, sponsored by Johns Hopkins University.
NCT01416584 is a NA study that has completed, run by Johns Hopkins University. The registered enrollment target is 98 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01416584, a NA study, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- NA
- Development phase
- 98 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the effectiveness of the Therapeutic Workplace in promoting methadone treatment and increasing abstinence in unemployed, out-of-treatment injection heroine users.
Primary Outcome
The percentage of months in which participants were enrolled in methadone treatment during the 6-month intervention evaluation period?
Interventions
- BEHAVIORAL methadone contingency
- BEHAVIORAL Methadone & Abstinence Contingency
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 98 participants |
| Start Date | 2008-10 |
| Est. Completion | 2014-04 |
| Phase | NA |
What the finished NCT01416584 record still lists
NCT01416584 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 98 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 0 conditions, and to 2 interventions - of which methadone contingency is the first listed.
NCT01416584 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01416584 about?
NCT01416584 is a clinical study titled "A Bridge to Treatment: The Therapeutic Workplace and Methadone Treatment". The purpose of this study is to evaluate the effectiveness of the Therapeutic Workplace in promoting methadone treatment and increasing abstinence in unemployed, out-of-treatment injection heroine users.
What is the current status of trial NCT01416584?
This trial is currently completed. It is a NA study. The enrollment target is 98 participants. The study started on 2008-10. Estimated completion is 2014-04.
What interventions are being tested in trial NCT01416584?
The interventions under investigation include: methadone contingency (BEHAVIORAL), Methadone & Abstinence Contingency (BEHAVIORAL).
Who is sponsoring clinical trial NCT01416584?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01416584's enrollment target sits among peer trials
98 922nd of 2000 higher than 1,078 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02926729 · 98 participants · NA
Real-Time Assessment Of Breast Cancer Lumpectomy Specimen Margins With Nonlinear Microscopy
- NCT03382977 · 98 participants · Phase 1
Study to Evaluate Safety, Tolerability, and Optimal Dose of Candidate GBM Vaccine VBI-1901 in Recurrent GBM Subjects
- NCT04577014 · 98 participants · Phase 1
Retifanlimab (Anti-PD-1 Antibody) With Gemcitabine and Docetaxel in Patients With Advanced Soft Tissue Sarcoma
- NCT04817618 · 98 participants · Phase 3
Study of Efficacy and Safety of Iptacopan in Patients With C3 Glomerulopathy.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia